Market Overview

Morning Market Movers

Share:
Related ALNY
Q2 Earnings Report Card: Biotech
Alnylam Pharma's Pipeline Offers Plenty Upside Potential
Prothena Builds Case For Amyloidosis Valuation (Seeking Alpha)
Related MRK
The 2015 Flash Crash Was One Year Ago Today. Why Did It Happen?
Write A Prescription For More Pharma M&A With This ETF
Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth (GuruFocus)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!